PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Antonio, Texas
November 09 2022 - 8:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company") an
emerging biomedical device company focused on the commercialization
of innovative medical devices and therapeutics for companion
animals announced today it will be exhibiting at the American
Association Equine Practitioners (“AAEP”) conference to be held
November 19th to November 22nd, 2022 at the Henry B. Gonzalez
Convention Center in San Antonio, Texas.
PetVivo intends to exhibit its lead product,
SPRYNG™ with OsteoCushion™ Technology, a medical device injection
of sterilized, extra-cellular matrix microparticles that are
lubricious and spongy used in the treatment of lameness and other
joint related afflictions, such as osteoarthritis. The AAEP is the
largest veterinary equine conference that services the United
States, and normally plays host to more than 5,000 participants
including many of the top industry professionals.
“We are looking forward to networking with
leaders in the industry and develop relationships that will help
drive forward our initial veterinary medical device, SPRYNG, for
the management of lameness issues, including conditions related to
osteoarthritis, in our family members and equine athletes,” said
John Lai, Chief Executive Officer of PetVivo Holdings, Inc.
Furthermore, Joseph Manning, DVM, Senior
Technical Veterinarian for PetVivo, will be a presenter for the
Product Demo Theater during for the 2022 AAEP Trade Show in San
Antonio, November 19-21. Dr. Manning will discuss the use of
Spryng™ with OsteoCushion™ Technology in “Managing Lameness and
Joint Issue with Confidence”. If you would like to attend a
presentation by Dr. Manning the details are provided below.
For more information about PetVivo Holdings,
Inc. please contact info1@petvivo.com or visit
https://petvivo.com/
Conference Exhibit Details:
American Association of Equine Practitioners
Conference (AAEP)
Booth #: 6082
Dates:
Saturday, November 19: 10:00 a.m. - 6:00
p.m.
Sunday, November 20: 10:00 a.m. - 6:00 p.m.
Monday, November 21: 10:00 a.m. - 4:00 p.m.
Location: Henry B. Gonzalez Convention Center in
San Antonio, Texas
Dr. Joseph Manning Presentation
Schedule:
Presentation Title: Manage Lameness and Joint
Issues with Confidence
Presentation 1 Date: Saturday, November 19:
12:30 p.m. - 1:00 p.m.
Presentation 2 Date: Sunday, November 20: 12:30
p.m. - 1:00 p.m.
Location for Presentation 1: Henry B. Gonzalez
Convention Center in San Antonio, Texas; Theatre 1
Location for Presentation 2: Henry B. Gonzalez
Convention Center in San Antonio, Texas; Theatre 2
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG™
with OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale.
For more information about PetVivo Holdings,
Inc. and our revolutionary product, Spryng with OsteoCushion
Technology, please contact info1@petvivo.com or visit
https://petvivo.com/
CONTACT:John Lai, CEOPetVivo Holdings,
Inc.Email: info1@petvivo.com(952) 405-6216
Forward-Looking Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements are
based on information currently available to the Company and its
current plans or expectations and are subject to a number of
uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024